AM Best affirmed the Aetna Health & Life Group and CVS Caremark Indemnity ratings with a stable outlook, citing strong capitalization and earnings. The release notes CVS Health contributed capital in 2024–25 to support losses, and highlights Oak Street Health goodwill impairment, signaling leverage challenges; Aetna's 2026 ACA market exit could affect profitability and capital needs.
Ratings affirmations with a stable outlook reduce near-term rating risk but do not signal material upside or downside for CVS stock; leverage and goodwill issues linger, limiting upside; thus neutral near term with potential for modest upside if leverage improves.
In 12–18 months, CVS benefits from stable insurance ratings, but leverage risk remains a key derisking hurdle.
Category: Industry News. The piece centers on AM Best's credit-rating activity for CVS-related insurers and affiliates, influencing perceived financial flexibility and leverage risk for CVS.